SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes
Blood (2003) 102 (3): 795–801.
Currently there are no citedby results. Try again later.
